Paul Rubin,Toshihiko Takeuchi,Hassan Issafras,Kiranjit Ahluwalia,John Corbin,lra Goldfine,Kirk Johnson,Ou Li,Daniel Bedinger
申请号：
US15897852
公开号：
US20180251562A1
申请日:
2018.02.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure relates, in general, to methods of treating or preventing hypoglycemia using a negative modulator antibody fragment that binds to the insulin receptor and modulates the action of insulin at the insulin receptor.
